The development and validation of tau PET tracers: current status and future directions
ConclusionsTau PET tracers have enabled in vivo quantification of PHF-tau burden in human brains. Tau PET can help in understanding the underlying cause of dementia symptoms, and in patient selection for clinical trials of anti-dementia therapies.
Source: Clinical and Translational Imaging - Category: Radiology Source Type: research
More News: Alzheimer's | Brain | Clinical Trials | Dementia | Neurology | Pathology | PET Scan | Progressive Supranuclear Palsy | Radiology | Study